Synplogen is a DNA synthesis startup spun out of Kobe University's Graduate School of Science, Technology and Innovation in February, 2017. Combining its proprietary OGAB techniques with cutting edge genetic engineering, information science and robotics, Synplogen provides a variety of services incl more
Nouscom is a private oncology company developing next generation immunotherapies. Nouscom's proprietary technology platform, Exovax, harnesses the full power of immune response by combining viral vectored genetic vaccines based on neoantigens with other immunomodulators.
Nouscom is led by an exper more
Topas Therapeutics GmbH is a clinical-stage biotechnology company focused on developing novel treatments in areas where patients are in need of more effective options, including autoimmune diseases, allergies and anti-drug immune responses. The Topas Particle Conjugates platform induces antigen-spec more